Related Experiment Video
Updated: May 27, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Estimation of total mediation effect for a binary trait in a case-control study for high-dimensional omics mediators†
Zhiyu Kang1, Li Chen2, Peng Wei3
1Division of Biostatistics and Health Data Science, University of Minnesota, MN 55455.
This study introduces a new method for mediation analysis, especially for binary outcomes and high-dimensional data. It reveals that metabolomics explains 89% of BMI
Area of Science:
- Biostatistics
- Genetics
- Epidemiology
Background:
- Mediation analysis identifies intermediate variables linking exposures to outcomes.
- Traditional methods struggle with high-dimensional mediators and binary outcomes, especially in case-control studies.
- Existing approaches may miss weak effects due to cancellation of opposing component effects.
Purpose of the Study:
- To propose a novel total mediation effect measure for high-dimensional mediators and binary outcomes.
- To provide a causal interpretation applicable to various mediation models.
- To address limitations of existing methods in capturing weak effects and handling binary outcomes.
Main Methods:
- Developed a new total mediation effect measure within the liability framework.
- Utilized a cross-fitted, modified Haseman-Elston regression for estimation.
- Tailored the procedure for case-control studies, adaptable to cohort studies.
Main Results:
- The proposed estimator is consistent, even with non-mediators and weak effect sizes, as shown in simulations.
- Demonstrated the method's efficacy in a real-world study.
- Found that 89% (CI: 73%-91%) of BMI-associated coronary heart disease liability variation is explained by metabolomics in the Women's Health Initiative.
Conclusions:
- The new liability-based mediation measure offers a robust causal interpretation for high-dimensional data.
- The developed estimation procedure is effective for case-control and cohort studies.
- Metabolomics plays a significant role in mediating the relationship between BMI and coronary heart disease liability.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
08:27Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Chi-square Analysis
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
Polygenic Traits
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Odds Ratio
Mechanistic Models: Compartment Models in Individual and Population Analysis